Sevene, Esperança
Banda, Clifford G.
Mukaka, Mavuto
Maculuve, Sonia
Macuacua, Salésio
Vala, Anifa
Piqueras, Mireia
Kalilani-Phiri, Linda
Mallewa, Jane
Terlouw, Dianne J.
Khoo, Saye H.
Lalloo, David G.
Mwapasa, Victor
Clinical trials referenced in this document:
Documents that mention this clinical trial
Efficacy and safety of artemether–lumefantrine as treatment for Plasmodium falciparum uncomplicated malaria in adult patients on efavirenz-based antiretroviral therapy in Zambia: an open label non-randomized interventional trial
https://doi.org/10.1186/s12936-019-2818-7
Efficacy and safety of dihydroartemisinin–piperaquine for treatment of Plasmodium falciparum uncomplicated malaria in adult patients on antiretroviral therapy in Malawi and Mozambique: an open label non-randomized interventional trial
https://doi.org/10.1186/s12936-019-2909-5
Funding for this research was provided by:
European and Developing Countries Clinical Trials Partnership (IP.07.31060.003)
Article History
Received: 14 February 2019
Accepted: 12 August 2019
First Online: 20 August 2019
Ethics approval and consent to participate
: The trial received ethics approval from the College of Medicine Research and Ethics Committee, Malawi; Comité Nacional de Bioética para Saúde, Mozambique and Liverpool School of Tropical Medicine Research Committee, UK and regulatory approval from the Pharmacy Medicines and Poisons Board, Malawi and Ministério da Saúde, Departamento Farmacêutico, Mozambique. Written informed consent was sought from all participants aged ≥ 18 years. Assent was sought from those who were aged < 18 years.
: Written informed consent to publish the data was sought from all participants aged ≥ 18 years. Assent was sought from those who were aged < 18 years, except for “mature minors”.
: The authors declare that they have no competing interests.